BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 29247993)

  • 1. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
    Chan BCL; Lam CWK; Tam LS; Wong CK
    Front Immunol; 2019; 10():364. PubMed ID: 30886621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
    Cayrol C
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33 and Behçet disease: Another cytokine among others.
    Hamzaoui K; Bouali E; Hamzaoui A
    Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population.
    Queiroz GA; Costa RS; Alcantara-Neves NM; Nunes de Oliveira Costa G; Barreto ML; Carneiro VL; Figueiredo CA
    Int J Immunogenet; 2017 Apr; 44(2):51-61. PubMed ID: 28266165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
    Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-33 in innate-type immune cells in allergy.
    Nakae S; Morita H; Ohno T; Arae K; Matsumoto K; Saito H
    Allergol Int; 2013 Mar; 62(1):13-20. PubMed ID: 23439054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight.
    Andreone S; Gambardella AR; Mancini J; Loffredo S; Marcella S; La Sorsa V; Varricchi G; Schiavoni G; Mattei F
    Front Immunol; 2020; 11():571593. PubMed ID: 33329534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of interleukin-33 and type 2 inflammation in asthma.
    Gordon ED; Simpson LJ; Rios CL; Ringel L; Lachowicz-Scroggins ME; Peters MC; Wesolowska-Andersen A; Gonzalez JR; MacLeod HJ; Christian LS; Yuan S; Barry L; Woodruff PG; Ansel KM; Nocka K; Seibold MA; Fahy JV
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8765-70. PubMed ID: 27432971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
    Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
    Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 in Malignancies: Friends or Foes?
    Shen JX; Liu J; Zhang GJ
    Front Immunol; 2018; 9():3051. PubMed ID: 30619376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin-33: from biology to potential treatments].
    Schmitt P; Girard JP; Cayrol C
    Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
    Lu B; Yang M; Wang Q
    J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.
    Molofsky AB; Savage AK; Locksley RM
    Immunity; 2015 Jun; 42(6):1005-19. PubMed ID: 26084021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
    Kaur H; Kaur G; Ali SA
    Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.